Home
  • ABOUT US
    • Corporate Profile
    • Management
    • Contact Us
  • Medical Conditions
    • dry-AMD
    • Stargardt disease
    • Leber's Optic Neuropathy
  • RESEARCH
    • Visual Cycle
    • Pre-clinical results
  • CLINICAL
    • Future Trials
    • Stargardt's Registry
  • NEWS
    • Press Releases
    • Alkeus in the News
    • Publications
  • CAREERS
    • Current Openings
A A

NEWS

  • Press Releases
  • Alkeus in the News
  • Publications

PRESS RELEASES

05/23/2012 Joshua Boger, founder and retired CEO of Vertex Pharmaceuticals to serve as Alkeus Executive Chairman
05/17/2011 Lab Study Shows an Improved Form of Vitamin A May Help Prevent Blindness
01/04/2011 Alkeus Pharmaceuticals Licenses Novel Compounds from Columbia University for Potential Treatments of Ophthalmologic Conditions such as Dry-AMD and Stargardt disease
08/30/2010 Alkeus to Present at the 2010 Conference on Clinical Research for Rare Diseases

About Alkeus

  • Corporate Profile
  • Management
  • Contact us

Medical Conditions

  • Dry-AMD
  • Stargardt disease
  • Leber's Optic Neuropathy

Research

  • Visual Cycle
  • Pre-clinical results

Clinical

  • Future Trials
  • Stargardt's Registry

News

  • Press Releases
  • Alkeus in the News
  • Publications

Careers

  • Current Openings
© 2011 - Alkeus Pharmaceuticals, Inc.